Novel IRAK-4 inhibitors exhibit highly potent anti-proliferative activity in DLBCL cell lines with activating MYD88 L265P mutation
- Resource Type
- Journal
- Source
CANCER RESEARCH ; AUG 1 2015, 75 1p. Supplement: 15- Subject
- Language
- English
- ISSN
- 15387445